Galapagos NV
GLPG
#4838
Rank
$1.92 B
Marketcap
$28.70
Share price
0.49%
Change (1 day)
17.91%
Change (1 year)

Galapagos NV (GLPG) - Total assets

Total assets on the balance sheet as of September 2025 : $4.12 Billion USD

According to Galapagos NV's latest financial reports the company's total assets are $4.12 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Galapagos NV - Total assets on balance sheet (from 2008 to 2025)

Total assets by year

Year Total assets Change
2024-12-31$4.30 B-10.65%
2023-12-31$4.81 B-5.15%
2022-12-31$5.07 B-13.65%
2021-12-31$5.88 B-16.37%
2020-12-31$7.03 B3.45%
2019-12-31$6.79 B312.82%
2018-12-31$1.64 B6.7%
2017-12-31$1.54 B35.44%
2016-12-31$1.13 B135.51%
2015-12-31$0.48 B47.09%
2014-12-31$0.32 B-17.11%
2013-12-31$0.39 B27.49%
2012-12-31$0.31 B48.83%
2011-12-31$0.20 B-18.93%
2010-12-31$0.25 B25.3%
2009-12-31$0.20 B23.95%
2008-12-31$0.16 B-23.5%
2007-12-31$0.21 B-1.83%
2006-12-31$0.22 B128.95%
2005-12-31$96.61 M356.2%
2004-12-31$21.17 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
$199.21 B 4,733.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$86.71 B 2,003.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$133.96 B 3,150.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$148.96 B 3,514.24%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
$136.86 B 3,220.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$114.07 B 2,667.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
$82.30 B 1,897.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
$0.18 B-95.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$40.74 B 888.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel